Louise Hill Presents NeoVanc Sub-study Results at ESPID 2020
2020
Louise Hill presented the findings of a NeoVanc sub-study at ESPID’s 2020 Virtual Meeting in late October. Below is a summary of the study and findings.
NeoVanc: pivotal achievement of 200 participants enrolled in the study
2019
We are pleased to celebrate the milestone achievement of the randomisation of 200 participants in the NeoVanc project. Congratulations to all the NeoVanc team!